INTESTINAL MUCOSAL IMMUNOGLOBULINS DURING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION

被引:63
作者
JANOFF, EN
JACKSON, S
WAHL, SM
THOMAS, K
PETERMAN, JH
SMITH, PD
机构
[1] NIDR,IMMUNOL LAB,CELLULAR IMMUNOL SECT,BETHESDA,MD 20892
[2] UNIV ALABAMA,DEPT MICROBIOL,BIRMINGHAM,AL 35294
[3] UNIV ALABAMA,DEPT MED,BIRMINGHAM,AL 35294
关键词
D O I
10.1093/infdis/170.2.299
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In intestinal fluid samples from 39 human immunodeficiency virus type 1 (HIV-1)-infected patients, IgA and IgG levels were equivalent, whereas in 10 controls, IgA levels were significantly higher than those of IgG (P < .05). Intestinal IgA in patients contained predominantly monomeric IgA1, whereas IgA1 and IgA2 subclass levels in controls were nearly equivalent and primarily polymeric. The predominance of IgG and monomeric IgA1 in mucosal fluid samples from HIV-1-infected patients suggests exudation of serum immunoglobulins into the intestine. The decreased proportion of mucosal plasma cells producing IgA and IgA2 in the HIV-1-infected patients (P < .01) may also contribute to the abnormal intestinal immunoglobulin levels. Intestinal IgG reacted with most HIV-1 antigens, whereas specific IgA was present in only 10 of 17 patients and reacted with only envelope (gp120 and gp160) and, less often, core (p17 and p24) antigens. Aberrant mucosal antibody responses and decreased integrity of the mucosal barrier may contribute to the intestinal dysfunction and infections that characterize HIV-1 infection.
引用
收藏
页码:299 / 307
页数:9
相关论文
共 78 条
[1]   ASSOCIATION OF CIRCULATING RECEPTOR FC-GAMMA-RIII-POSITIVE MONOCYTES IN AIDS PATIENTS WITH ELEVATED LEVELS OF TRANSFORMING GROWTH-FACTOR-BETA [J].
ALLEN, JB ;
WONG, HL ;
GUYRE, PM ;
SIMON, GL ;
WAHL, SM .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (05) :1773-1779
[2]   B-CELL ACTIVATION DURING HIV-1 INFECTION .3. DOWN-REGULATING EFFECT OF MITOGENS [J].
AMADORI, A ;
ZAMARCHI, R ;
VERONESE, ML ;
PANOZZO, M ;
MAZZA, MR ;
BARELLI, A ;
BORRI, A ;
CHIECOBIANCHI, L .
AIDS, 1991, 5 (07) :821-828
[3]   ANTIBODIES TO HUMAN-IMMUNODEFICIENCY-VIRUS IN CERVICAL SECRETIONS FROM WOMEN AT RISK FOR AIDS [J].
ARCHIBALD, DW ;
WITT, DJ ;
CRAVEN, DE ;
VOGT, MW ;
HIRSCH, MS ;
ESSEX, M .
JOURNAL OF INFECTIOUS DISEASES, 1987, 156 (01) :240-241
[4]  
ARCHIBALD DW, 1986, BLOOD, V67, P831
[5]   SECRETORY IGA ANTIBODIES TO HUMAN-IMMUNODEFICIENCY-VIRUS IN THE PAROTID-SALIVA OF PATIENTS WITH AIDS AND AIDS-RELATED COMPLEX [J].
ARCHIBALD, DW ;
BARR, CE ;
TOROSIAN, JP ;
MCLANE, MF ;
ESSEX, M .
JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (04) :793-796
[6]  
BEHETS FM, 1991, J ACQ IMMUN DEF SYND, V4, P183
[7]   ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS IN VAGINAL SECRETIONS OF HETEROSEXUAL WOMEN [J].
BELEC, L ;
GEORGES, AJ ;
STEENMAN, G ;
MARTIN, PMV .
JOURNAL OF INFECTIOUS DISEASES, 1989, 160 (03) :385-391
[8]  
BELEC L, 1990, PEDIATRICS, V85, P1022
[9]   IDENTIFICATION OF A CD21 RECEPTOR-DEFICIENT, NON-IG-SECRETING PERIPHERAL LYMPHOCYTE-B SUBSET IN HIV-SEROPOSITIVE DRUG-ABUSERS [J].
BENEDETTO, A ;
DICARO, A ;
CAMPORIONDO, MP ;
GALLONE, D ;
ZANIRATTI, S ;
TOZZI, V ;
ELIA, G .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 62 (02) :139-147
[10]  
BERBERIAN L, 1991, BLOOD, V78, P175